Bowel cancer: Experimental drug found to cause tumours to disappear in 100% of patients
msn.comREAD MORE: High cholesterol: Cramp in five areas of the body can be a signHowever, while this is a positive step in the right direction for bowel cancer treatment, there is one caveat to the study; there were only 12 participants in the study.
As a result, more research is required into a larger patient cohort in order to establish dostarlimab's overall efficacy against bowel cancer.
If dostarlimab shows the same effectiveness across a much larger group, it could transform cancer care for thousands of patients around the world.
Further details of the trial have been published in the New England Journal of Medicine. DON'T MISSNaga Munchetty health: BBC star on her painful injury - symptoms [CELEBRITY HEALTH]Covid: Millions of patients may have potentially fatal undiagnosed con [CORONAVIRUS]Shingles and monkeypox: How to tell the difference [MONKEYPOX]Subsequently, while the trial is positive news for patients of the future or those in the early stages of treatment for bowel cancer, it is far too late for thousands of patients of the present.
Read more on msn.com